The one in the States, being guided by Gendleman at Univ of Neb and the one in Europe, which you link to, which is being aimed selectively at alpha synuclein.

I also like the fact that both strategies seem based on the premise that PD is a neuro/immune inflammatory condition, because I happen to strongly believe that they are absolutely correct.

Cal